LONDON, June 17 (Reuters) - British drugmaker GlaxoSmithKline is investing $95 million to create a new U.S. research institute led by a top genomics professor to investigate how a cell's operating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback